首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Efficacy of propranolol and pingyangmycin respectively combined with pulsed dye laser on children with hemangioma
【2h】

Efficacy of propranolol and pingyangmycin respectively combined with pulsed dye laser on children with hemangioma

机译:普萘洛尔和平阳霉素联合脉冲染料激光治疗血管瘤患儿的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clinical efficacy of propranolol and pingyangmycin, respectively, combined with pulsed dye laser in the treatment of children with hemangioma was analyzed, to provide a new therapeutic idea for their clinical treatment. A total of 120 children with hemangioma were selected into the study. Children treated with propranolol combined with pulsed dye laser were in group A, those treated with pingyangmycin combined with pulsed dye laser were in group B, and 60 healthy children were selected as control group (group C). Blood samples of children were taken before and after treatment for miR-4295 detection. The expression of miR-4295 was observed after treatment, and the total clinical remission rate and adverse reactions after treatment were compared between the two groups. The tumor volume of the two groups was significantly reduced after treatment, with statistically significant difference (P<0.05); miR-4295 expression was reduced in the two groups (P<0.05); adverse reactions in propranolol group were less than pingyangmycin group during treatment (P<0.05). Propranolol and pingyangmycin, respectively, combined with pulsed dye laser had ideal efficacy on hemangioma in children. Moreover, miR-4295 was highly expressed in children with hemangioma, and the expression level reduced after two methods of treatment. However, adverse reactions in propranolol group were less and its safety was higher.
机译:分析了普萘洛尔和平阳霉素分别联合脉冲染料激光治疗小儿血管瘤的临床疗效,为他们的临床治疗提供了新的治疗思路。总共选择了120名患有血管瘤的儿童进入研究。普萘洛尔联合脉冲染料激光治疗的患儿为A组,平阳霉素联合脉冲染料激光治疗的患儿为B组,选择60例健康儿童作为对照组(C组)。在治疗前后对儿童的血样进行miR-4295检测。治疗后观察miR-4295的表达,比较两组的总临床缓解率和治疗后不良反应。两组治疗后肿瘤体积明显缩小,差异有统计学意义(P <0.05);两组miR-4295表达均降低(P <0.05);治疗期间普萘洛尔组不良反应少于平阳霉素组(P <0.05)。普萘洛尔和平阳霉素分别联合脉冲染料激光治疗小儿血管瘤疗效理想。此外,miR-4295在血管瘤患儿中高表达,两种治疗方法后表达水平降低。但普萘洛尔组不良反应少,安全性高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号